Clinical trial
Molecular Analysis of Patients With Neuromuscular Disease
NCT00390104 · Boston Children's Hospital, Other · Recruiting
Key facts
| NCT number | NCT00390104 |
|---|---|
| Title | Molecular Analysis of Patients With Neuromuscular Disease |
| Official title | Molecular Analysis of Nucleic Acids Derived From Patients With Neuromuscular Disease and Their Family Members |
| Lead sponsor | Boston Children's Hospital, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Neuromuscular, Disorder, Hereditary, Duchenne/Becker Muscular Dystrophy, Limb-girdle Muscular Dystrophy |
| Enrollment | 1,000 |
| Start date | Jan 1, 2002 |
| Primary completion | Dec 31, 2026 |
| Completion | Dec 31, 2027 |
| First posted | Oct 19, 2006 |
| Last update posted | Apr 24, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: